| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |